The Fogel Lab seeks to understand the basic and fundamental molecular mechanisms underlying human neurodevelopment and neurodegenerative disease. Under the direction of the Principal Investigator, Dr. Brent Fogel, we are currently examining how specific genes and genetic pathways influence the development of two classes of neurogenetic disease, cerebellar ataxia and autism spectrum disorder. Our goal is to better understand the molecular basis of these diseases to improve diagnosis and develop new strategies for better clinical treatments for patients and their families.